Total Funding
1
1
Total FundingSeries C raised
Growth Score
0 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
404692
NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.
Nathalie Muller: Corporate Secretary, Director Administration and Legal AffairsPast Role: Meda Biotech, Head of Administration and Legal Affairs
About the Company
NovImmmune is committed to innovation by discovering and developing therapeutic monoclonal antibodies (mAbs) to treat patients suffering from immune-related disorders.
